Regulus Therapeutics
RGLS
#7340
Rank
โ‚น54.64 B
Marketcap
โ‚น789.32
Share price
0.00%
Change (1 day)
485.06%
Change (1 year)

Regulus Therapeutics (RGLS) - Total assets

Total assets on the balance sheet as of March 2025 : โ‚น7.23 Billion

According to Regulus Therapeutics's latest financial reports the company's total assets are โ‚น7.23 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regulus Therapeutics - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น7.22 B182.1%
2023-12-31โ‚น2.55 B-33.78%
2022-12-31โ‚น3.86 B-24.13%
2021-12-31โ‚น5.09 B85.27%
2020-12-31โ‚น2.75 B-8.35%
2019-12-31โ‚น3.00 B53.67%
2018-12-31โ‚น1.95 B-60.7%
2017-12-31โ‚น4.96 B-27.37%
2016-12-31โ‚น6.84 B-27.04%
2015-12-31โ‚น9.37 B-13.73%
2014-12-31โ‚น10.86 B42.95%
2013-12-31โ‚น7.60 B34.14%
2012-12-31โ‚น5.66 B149.86%
2011-12-31โ‚น2.26 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sanofi
SNY
โ‚น14.248 T 196,756.71%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น3.103 T 42,781.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.476 T 117,017.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น11.204 T 154,703.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น7.913 T 109,229.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
โ‚น5.80 B-19.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น537.69 B 7,328.93%๐Ÿ‡บ๐Ÿ‡ธ USA